Fresenius Medical Care AG & Co. KGaA (FME.DE)
EUR 45.06
(-0.09%)
EUR 45.06
(-0.09%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.17 Billion EUR | -5.1% |
| 2022 | 2.29 Billion EUR | 12.67% |
| 2021 | 2.03 Billion EUR | 7.53% |
| 2020 | 1.89 Billion EUR | 13.95% |
| 2019 | 1.66 Billion EUR | 13.39% |
| 2018 | 1.46 Billion EUR | 13.64% |
| 2017 | 1.29 Billion EUR | -3.71% |
| 2016 | 1.34 Billion EUR | 9.31% |
| 2015 | 1.22 Billion EUR | 33.68% |
| 2014 | 917.38 Million EUR | 15.47% |
| 2013 | 794.5 Million EUR | 1.34% |
| 2012 | 783.97 Million EUR | 5.02% |
| 2011 | 746.47 Million EUR | 22.7% |
| 2010 | 608.36 Million EUR | 6.08% |
| 2009 | 573.48 Million EUR | 12.91% |
| 2008 | 507.9 Million EUR | 16.39% |
| 2007 | 436.37 Million EUR | 9.92% |
| 2006 | 396.97 Million EUR | 9.12% |
| 2005 | 363.8 Million EUR | 11.35% |
| 2004 | 326.73 Million EUR | -7.48% |
| 2003 | 353.13 Million EUR | -0.45% |
| 2002 | 354.71 Million EUR | -8.89% |
| 2001 | 389.31 Million EUR | 14.18% |
| 2000 | 340.96 Million EUR | 13.87% |
| 1999 | 299.43 Million EUR | 18.08% |
| 1998 | 253.58 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 2.21 Billion EUR | 1.69% |
| 2024 Q3 | 2.1 Billion EUR | -5.72% |
| 2024 Q2 | 2.22 Billion EUR | 0.52% |
| 2023 FY | 2.17 Billion EUR | -5.1% |
| 2023 Q1 | 2.32 Billion EUR | 1.39% |
| 2023 Q2 | 2.33 Billion EUR | 0.32% |
| 2023 Q3 | 2.3 Billion EUR | -1.35% |
| 2023 Q4 | 2.17 Billion EUR | -5.41% |
| 2022 Q4 | 2.29 Billion EUR | -4.71% |
| 2022 FY | 2.29 Billion EUR | 12.67% |
| 2022 Q3 | 2.4 Billion EUR | 5.74% |
| 2022 Q1 | 2.13 Billion EUR | 4.86% |
| 2022 Q2 | 2.27 Billion EUR | 6.64% |
| 2021 Q4 | 2.03 Billion EUR | -3.86% |
| 2021 Q1 | 1.98 Billion EUR | 4.96% |
| 2021 Q2 | 2.05 Billion EUR | 3.19% |
| 2021 Q3 | 2.11 Billion EUR | 3.26% |
| 2021 FY | 2.03 Billion EUR | 7.53% |
| 2020 Q2 | 1.84 Billion EUR | 5.61% |
| 2020 Q4 | 1.89 Billion EUR | -0.09% |
| 2020 Q3 | 1.89 Billion EUR | 3.05% |
| 2020 Q1 | 1.74 Billion EUR | 4.8% |
| 2020 FY | 1.89 Billion EUR | 13.95% |
| 2019 Q3 | 1.72 Billion EUR | 1.99% |
| 2019 Q4 | 1.66 Billion EUR | -3.36% |
| 2019 Q2 | 1.68 Billion EUR | -0.48% |
| 2019 Q1 | 1.69 Billion EUR | 15.6% |
| 2019 FY | 1.66 Billion EUR | 13.39% |
| 2018 Q4 | 1.46 Billion EUR | 0.9% |
| 2018 Q1 | 1.35 Billion EUR | 4.94% |
| 2018 FY | 1.46 Billion EUR | 13.64% |
| 2018 Q2 | 1.39 Billion EUR | 2.89% |
| 2018 Q3 | 1.45 Billion EUR | 4.32% |
| 2017 Q1 | 1.34 Billion EUR | 0.35% |
| 2017 FY | 1.29 Billion EUR | -3.71% |
| 2017 Q4 | 1.29 Billion EUR | -1.39% |
| 2017 Q3 | 1.3 Billion EUR | 1.14% |
| 2017 Q2 | 1.29 Billion EUR | -3.79% |
| 2016 Q4 | 1.34 Billion EUR | 6.92% |
| 2016 Q1 | 1.22 Billion EUR | -0.34% |
| 2016 FY | 1.34 Billion EUR | 9.31% |
| 2016 Q2 | 1.24 Billion EUR | 1.83% |
| 2016 Q3 | 1.25 Billion EUR | 0.75% |
| 2015 Q2 | 1.07 Billion EUR | 0.59% |
| 2015 Q1 | 1.07 Billion EUR | 16.71% |
| 2015 FY | 1.22 Billion EUR | 33.68% |
| 2015 Q4 | 1.22 Billion EUR | 4.51% |
| 2015 Q3 | 1.17 Billion EUR | 8.95% |
| 2014 FY | 917.38 Million EUR | 15.47% |
| 2014 Q1 | 877.44 Million EUR | 10.44% |
| 2014 Q2 | 937.79 Million EUR | 6.88% |
| 2014 Q3 | 934.03 Million EUR | -0.4% |
| 2014 Q4 | 917.38 Million EUR | -1.78% |
| 2013 FY | 794.5 Million EUR | 1.34% |
| 2013 Q4 | 794.5 Million EUR | 1.78% |
| 2013 Q1 | 840.66 Million EUR | 7.23% |
| 2013 Q2 | 810.99 Million EUR | -3.53% |
| 2013 Q3 | 780.6 Million EUR | -3.75% |
| 2012 Q2 | 816.22 Million EUR | 6.33% |
| 2012 Q1 | 767.61 Million EUR | 2.83% |
| 2012 FY | 783.97 Million EUR | 5.02% |
| 2012 Q4 | 783.97 Million EUR | -1.9% |
| 2012 Q3 | 799.14 Million EUR | -2.09% |
| 2011 FY | 746.47 Million EUR | 22.7% |
| 2011 Q4 | 746.47 Million EUR | 9.21% |
| 2011 Q3 | 683.51 Million EUR | 1.29% |
| 2011 Q2 | 674.78 Million EUR | 17.75% |
| 2011 Q1 | 573.05 Million EUR | -5.8% |
| 2010 Q4 | 608.36 Million EUR | -2.33% |
| 2010 Q1 | 613.91 Million EUR | 7.05% |
| 2010 FY | 608.36 Million EUR | 6.08% |
| 2010 Q2 | 664.76 Million EUR | 8.28% |
| 2010 Q3 | 622.87 Million EUR | -6.3% |
| 2009 Q2 | 605.79 Million EUR | 3.79% |
| 2009 Q1 | 583.67 Million EUR | 14.92% |
| 2009 Q4 | 573.48 Million EUR | 0.0% |
| 2009 FY | 573.48 Million EUR | 12.91% |
| 2008 Q1 | 452.3 Million EUR | 3.65% |
| 2008 Q2 | 486.45 Million EUR | 7.55% |
| 2008 Q3 | 514.41 Million EUR | 5.75% |
| 2008 Q4 | 507.9 Million EUR | -1.27% |
| 2008 FY | 507.9 Million EUR | 16.39% |
| 2007 Q2 | 434.28 Million EUR | 2.34% |
| 2007 Q1 | 424.36 Million EUR | 6.9% |
| 2007 FY | 436.37 Million EUR | 9.92% |
| 2007 Q4 | 436.37 Million EUR | -0.23% |
| 2007 Q3 | 437.38 Million EUR | 0.72% |
| 2006 Q3 | 421.95 Million EUR | 2.53% |
| 2006 Q2 | 411.54 Million EUR | 0.0% |
| 2006 FY | 396.97 Million EUR | 9.12% |
| 2006 Q1 | - EUR | -100.0% |
| 2006 Q4 | 396.97 Million EUR | -5.92% |
| 2005 FY | 363.8 Million EUR | 11.35% |
| 2005 Q3 | 372.43 Million EUR | -0.81% |
| 2005 Q2 | 375.47 Million EUR | 7.78% |
| 2005 Q1 | 348.38 Million EUR | 6.63% |
| 2005 Q4 | 363.8 Million EUR | -2.32% |
| 2004 FY | 326.73 Million EUR | -7.48% |
| 2004 Q4 | 326.73 Million EUR | -8.66% |
| 2004 Q3 | 357.71 Million EUR | -2.67% |
| 2004 Q2 | 367.52 Million EUR | 1.15% |
| 2004 Q1 | 363.35 Million EUR | 2.89% |
| 2003 Q4 | 353.13 Million EUR | -3.6% |
| 2003 FY | 353.13 Million EUR | -0.45% |
| 2003 Q3 | 366.33 Million EUR | -0.57% |
| 2003 Q1 | 360.26 Million EUR | 1.56% |
| 2003 Q2 | 368.43 Million EUR | 2.27% |
| 2002 Q1 | 417.52 Million EUR | 7.25% |
| 2002 Q4 | 354.71 Million EUR | 0.0% |
| 2002 Q2 | 384.77 Million EUR | -7.84% |
| 2002 Q3 | - EUR | -100.0% |
| 2002 FY | 354.71 Million EUR | -8.89% |
| 2001 Q2 | 409.28 Million EUR | 7.78% |
| 2001 FY | 389.31 Million EUR | 14.18% |
| 2001 Q4 | 389.31 Million EUR | 0.0% |
| 2001 Q1 | 379.72 Million EUR | 11.37% |
| 2001 Q3 | - EUR | -100.0% |
| 2000 Q2 | 337.55 Million EUR | 7.37% |
| 2000 Q4 | 340.96 Million EUR | -2.35% |
| 2000 Q3 | 349.18 Million EUR | 3.44% |
| 2000 FY | 340.96 Million EUR | 13.87% |
| 2000 Q1 | 314.38 Million EUR | 4.99% |
| 1999 FY | 299.43 Million EUR | 18.08% |
| 1999 Q4 | 299.43 Million EUR | 0.0% |
| 1998 FY | 253.58 Million EUR | 0.0% |
| 1998 Q4 | 253.58 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Fresenius SE & Co. KGaA | 2.51 Billion EUR | 13.422% |
| LIMES Schlosskliniken AG | 80.12 Thousand EUR | -2719551.304% |
| M1 Kliniken AG | 45.52 Million EUR | -4686.631% |
| Maternus-Kliniken Aktiengesellschaft | 586 Thousand EUR | -371772.867% |
| MEDICLIN Aktiengesellschaft | 7.29 Million EUR | -29766.588% |
| RHÖN-KLINIKUM Aktiengesellschaft | 34.21 Million EUR | -6269.249% |
| VITA 34 AG | 3.4 Million EUR | -63899.266% |